Literature DB >> 10809438

Why should we implement living donation in renal transplantation?

A Tarantino1.   

Abstract

BACKGROUND: Renal transplantation started with living donor transplants. However, after the introduction of cyclosporine, the improved results of kidney transplants from cadaveric donors have raised controversy regarding the use of living donors. There are various reasons as to why some transplant centers tend to refuse living donation: first of all, the possibility that unilateral nephrectomy can be harmful to a healthy individual. SUBJECTS AND METHODS: By reviewing the medical literature on the various aspects of living donation, postoperative mortality in connection with living donation has been calculated to be 1:3,000.
RESULTS: Long-term follow-up investigations of donors demonstrated that the risk of progressive renal failure, hypertension, and proteinuria was not increased by nephrectomy per se, but other causes were responsible for that in occasional patients. From these studies, one can conclude that unilateral nephrectomy is not harmful to a healthy individual. In addition, there are other valid reasons to expand living donation: 1) the need for cadaveric donor kidneys for transplantation far exceeding the supply; 2) the better kidney quality from living donors due to the shorter ischemia time, the lack ofagonal phase and cytokines release that follows brain death; 3) the continuing improved results of kidney transplants from living donors in comparison with those from cadaveric donors in the cyclosporine era also. This appears to be true also for kidney transplants from unrelated living donors in spite of complete incompatibility with recipients. 4) Pre-emptive transplantation, based on living donors, not only avoids the risks, cost, and inconvenience of dialysis, but is also associated with better graft survival than transplantation after a period of dialysis, particularly within the live donor cohort.
CONCLUSIONS: In conclusion, living donor transplants should be part of any transplant center's activity. To encourage living donation, every center should have a formal recipient family education program in conjunction with national organ donation campaigns.

Entities:  

Mesh:

Year:  2000        PMID: 10809438

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

1.  Racial disparities in preemptive referral for kidney transplantation in Georgia.

Authors:  Jennifer C Gander; Xingyu Zhang; Laura Plantinga; Sudeshna Paul; Mohua Basu; Stephen O Pastan; Eric Gibney; Erica Hartmann; Laura Mulloy; Carlos Zayas; Rachel E Patzer
Journal:  Clin Transplant       Date:  2018-08-26       Impact factor: 2.863

2.  Design and approach of the Living Organ Video Educated Donors (LOVED) program to promote living kidney donation in African Americans.

Authors:  John C Sieverdes; Matthew Price; Kenneth J Ruggiero; Prabhakar K Baliga; Kenneth D Chavin; Brenda Brunner-Jackson; Sachin Patel; Frank A Treiber
Journal:  Contemp Clin Trials       Date:  2017-07-05       Impact factor: 2.226

3.  Understanding the relationship between trust in health care and attitudes toward living donor transplant among African Americans with end-stage renal disease.

Authors:  Evangeline L McDonald; C Lamonte Powell; Jennie P Perryman; Nancy J Thompson; Kimberly R Jacob Arriola
Journal:  Clin Transplant       Date:  2013-06-21       Impact factor: 2.863

4.  Your Path to Transplant: a randomized controlled trial of a tailored computer education intervention to increase living donor kidney transplant.

Authors:  Amy D Waterman; Mark L Robbins; Andrea L Paiva; John D Peipert; Crystal S Kynard-Amerson; Christina J Goalby; LaShara A Davis; Jessica L Thein; Emily A Schenk; Kari A Baldwin; Stacy L Skelton; Nicole R Amoyal; Leslie A Brick
Journal:  BMC Nephrol       Date:  2014-10-14       Impact factor: 2.388

5.  Survival After Simultaneous Pancreas-Kidney Transplantation in Type 1 Diabetes: The Critical Role of Early Pancreas Allograft Function.

Authors:  Mengmeng Ji; Mei Wang; Wenjun Hu; Mohamed Ibrahim; Krista Lentine; Massini Merzkani; Haris Murad; Yazen Al-Hosni; Ronald Parsons; Jason Wellen; Su-Hsin Chang; Tarek Alhamad
Journal:  Transpl Int       Date:  2022-09-12       Impact factor: 3.842

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.